Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
brii-196 (1 trial)
brii-198 (1 trial)
ly3819253 (1 trial)
remdesivir (Veklury) (2 trials)
vir-7831 (4 trials)
brii-179 (1 trial)
interferon alfa-1b (Rebif) (1 trial)
interferon alpha-2a (roferon-a) (3 trials)
nivolumab (opdivo) (1 trial)
selgantolimod (1 trial)
sotrovimab (Xevudy) (6 trials)
tenofovir (viread) (1 trial)
tenofovir alafenamide (genvoya) (1 trial)
vir-2218 (11 trials)
vir-2482 (2 trials)
vir-3434 (5 trials)
vir-1111 (1 trial)
vir-1388 (1 trial)
Hepatitis (Phase 2)
Hepatitis A (Phase 2)
Hepatitis B (Phase 2)
Hepatitis B, Chronic (Phase 2)
Hepatitis, Chronic (Phase 2)
Influenza, Human (Phase 2)
Trials (26 total)
Trial APIs (18 total)